Sung‐Bae Kim

42.0k citations

438 papers · 17.0k indexed · 10 hit papers · h-index 54

Impact in

Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
Cancer Research top 0.5%
- Breast Cancer Treatment Studies

Papers in

Oncology 253
- HER2/EGFR in Cancer Research 99
- Cancer Treatment and Pharmacology 89
- Cancer Immunotherapy and Biomarkers 43
Otorhinolaryngology 39
- Head and Neck Cancer Studies 39

Co-authors: Javier Cortés Emma Clark Mark Benyunes Sandra M. Swain Graham Ross Jean-Marc Ferrero Jungsil Ro Seock‐Ah Im
Journals: Journal of Clinical Oncology (85 papers)Cancer Research (21 papers)Cancer Research and Treatment (21 papers)Breast Cancer Research and Treatment (13 papers)European Journal of Cancer (12 papers)
Partner nations: South Korea United States Spain

In The Last Decade

Sung‐Bae Kim

411 papers receiving 16.7k citations

Hit Papers

10 papers align trajectories log scale

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial 2024 · 53 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Medicine
2020 The Lancet Oncology
2019 The Lancet Oncology
2018 JAMA Oncology
2017 The Lancet Oncology
2015 New England Journal of Medicine
2015 New England Journal of Medicine
2014 The Lancet Oncology
2013 The Lancet Oncology
2011 New England Journal of Medicine

Peers

Countries citing papers authored by Sung‐Bae Kim

Since Specialization

Citations

This map shows the geographic impact of Sung‐Bae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Bae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Bae Kim more than expected).

Fields of papers citing papers by Sung‐Bae Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Bae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Bae Kim. The network helps show where Sung‐Bae Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Sung‐Bae Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sung‐Bae Kim Line = papers co-authored together Sung‐Bae Kim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of HER2-Low Status on Pathologic Complete Response and Survival Outcome Among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy Journal of Breast Cancer ·Young Joo Lee, Tae-Kyung Yoo, Sae Byul Lee, Il Yong Chung, J.D.G. Laughton, M. Livneh, Jong Won Lee, Byung Ho Son, Sei Hyun Ahn, Hyehyun Jeong, Jae Ho Jeong, Jin‐Hee Ahn, Kyung Hae Jung, Sung‐Bae Kim, Hee Jin Lee, Gyungyub Gong, Jisun Kim	2025	0
2	Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (mBC): Updated survival results of DESTINY-Breast03. Journal of Clinical Oncology ·Erika Hamilton, Sara A. Hurvitz, Seock‐Ah Im, Hiroji Iwata, Giuseppe Curigliano, Sung‐Bae Kim, Michele Autore, José Luiz Pedrini, Wěi Li, Kan Yonemori, Giampaolo Bianchini, Sherene Loi, Giuliano Santos Borges, Xian Wang, Thomas Bachelot, Megan Roegner, Shahid Ashfaque, 実米口, Anton Egorov, Javier Cortés	2024	5
3	TransCon IL-2 β/γ alone or in combination with pembrolizumab, standard of care chemotherapy or TransCon TLR7/8 agonist in advanced/metastatic solid tumors: Updated results of the phase 1/2 IL Believe study. Journal of Clinical Oncology ·Alexander Starodub, Sung‐Bae Kim, Diwakar Davar, Oladapo Yeku, Andrew Hill, John D. Powderly, Nashat Gabrail, Christian Krapp, Ren Changy, 郭慧琳, Stina Mui Singel, Vineet Kwatra	2024	1
4	Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL. Journal of Clinical Oncology ·Yeon Hee Park, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, 幸恵内藤, Su‐Jin Koh, Ji‐Yeon Kim, Joohyuk Sohn, Sung‐Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock‐Ah Im	2024	1
5	Ipatasertib plus Paclitaxel for Patients with PIK3CA / AKT1 / PTEN -Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial Clinical Cancer Research ·Rebecca Dent, Sung‐Bae Kim, Mafalda Oliveira, Carlos H. Barrios, Joyce O’Shaughnessy, Steven J. Isakoff, Shigehira Saji, Ruffo Freitas‐Júnior, Shao-Ching Chang, Igor Bondarenko, Qinshu Lian, Denise Bradley, Heather Hinton, Matthew Wongchenko, Atul Babu Varshneya, Nicholas C. Turner	2024	9
6	Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) Cancers ·Yun‐Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Y. C. PATRY, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Keun‐Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung‐Bae Kim, Hyo Jung Kim, Hwan‐Jung Yun	2023	0
7	A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy Cancer Research and Treatment ·Young‐Woong Won, Jin‐Hyoung Kang, Jung Hye Kwon, Dong‐Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae‐Won Lee, Joohyuk Sohn, Sarah Soyeon Oh, Kyung Hee Lee, Su‐Jin Koh, Keun Seok Lee, Chan Kyu Kim, Jiyeon Kim, Jun Ho Ji, Sung‐Bae Kim, Jen Li Lai, Ho Young Kim	2023	1
8	Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Drug Safety ·Joanne Chiu, Soo Chin Lee, Jcm Ho, Yeon Hee Park, Ta‐Chung Chao, Sung‐Bae Kim, Elgene Lim, Ching‐Hung Lin, Sherene Loi, Su Ying Low, Lynette Teo, Winnie Yeo, Rebecca Dent	2023	16
9	Canine Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Attenuate Atopic Dermatitis Animals ·Chao Xia, Sung‐Bae Kim, Édith Lagacé, 陈卓陈卓, Catherine Alexandra Bergeson, J Stoia	2023	9
10	Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories Journal of Breast Cancer ·Suthinee Ithimakin, Napa Parinyanitikul, Sung‐Bae Kim, Yoon Sim Yap, Janice Tsang, Inda Soong, Yukinori Ozaki, Shinji Ohno, Makiko Ono, Jack Junjie Chan, Skye Hung‐Chun Cheng, Gonzalo Abraham Viñán Carrasco	2022	5
11	Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer Clinical Cancer Research ·Cristina Saura, Judit Matito, Mafalda Oliveira, Hans Wildiers, Carl Aberle, Simon Waters, Sara A. Hurvitz, Beverly Moy, Sung‐Bae Kim, William J. Gradishar, Geraldo Silva Queiroz, Eduardo Cronemberger, Gerald Wallweber, Judith D. Bebchuk, Kiana Keyvanjah, Alshad S. Lalani, Richard Bryce, Ana Vivancos, Lisa D. Eli, Suzette Delaloge	2021	15
12	Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma Clinical Cancer Research ·Eun Joo Kang, Myung‐Ju Ahn, Chan-Young Ock, Keun‐Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, Byung‐Ho Nam, Sung‐Bae Kim, Bhumsuk Keam	2021	39
13	CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience Journal of Breast Cancer ·Морунов В.В., Jae Ho Jeong, Jeong Eun Kim, Jin‐Hee Ahn, Kyung Hae Jung, Sung‐Bae Kim	2021	3
14	Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen Journal of Breast Cancer ·Kim G-Y, Zhen‐Yu Wu, Hee Jeong Kim, Jong Won Lee, Il Yong Chung, Jisun Kim, Sae Byul Lee, Byung Ho Son, Sung‐Bae Kim, Abdollah Rjaei-Khiavi, Gyungyub Gong, Sei Hyun Ahn, BeomSeok Ko	2020	7
15	Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial Journal of Clinical Oncology ·Aditya Bardia, Marina Parton, Sherko Kümmel, Laura García‐Estévez, Chiun‐Sheng Huang, Javier Cortés, Manuel Ruíz‐Borrego, Melinda L. Telli, Paloma Martín-Martorell, Rafael López‐López, J. Thaddeus Beck, Roohi Ismail‐Khan, Shin‐Cheh Chen, Sara A. Hurvitz, Ingrid A. Mayer, D. Carreon, Scott B. Cameron, Serena G. Liao, José Baselga, Sung‐Bae Kim	2018	55
16	Pembrolizumab (pembro) + chemotherapy (chemo) as neoadjuvant treatment for triple negative breast cancer (TNBC): Preliminary results from KEYNOTE-173. Journal of Clinical Oncology ·Peter Schmid, Yeon Hee Park, Eva Muñoz‐Couselo, Sung‐Bae Kim, Joohyuk Sohn, Seock‐Ah Im, Esther Holgado, Yang Wang, Thao P. Dang, Gursel Aktan, Javier Cortés	2017	68
17	An Introduction to a Head and Neck Cancer-Specific Frailty Index and Its Clinical Implications in Elderly Patients: A Prospective Observational Study Focusing on Respiratory and Swallowing Functions The Oncologist ·Minsu Kwon, Shinae Kim, Jong‐Lyel Roh, Sang-wook Lee, Sung‐Bae Kim, Seung‐Ho Choi, Soon Yuhl Nam, Sang Yoon Kim	2016	35
18	Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results Cancer Research and Treatment ·Yeon Hee Park, Tae Yong Kim, Young‐Hyuck Im, Roger C. Stevens, In Hae Park, Joohyuk Sohn, Soo Hyun Lee, Seock‐Ah Im, Jee Hyun Kim, Se Hyun Kim, Soo Jung Lee, Su-Jin Koh, Ki Hyeong Lee, Yoon Ji Choi, Eun Kyung Cho, Suee Lee, Seok Yun Kang, Jae Hong Seo, Sung‐Bae Kim, Kyung Hae Jung	2016	9
19	Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02 Journal of Clinical Oncology ·Winnie Yeo, Kyung Hae Jung, Seock‐Ah Im, Joohyuk Sohn, Jungsil Ro, Jin Hee Ahn, Sung‐Bae Kim, Byung‐Ho Nam, Do Youn Oh, Sae‐Won Han, Soo Hyun Lee, In Hae Park, Keun Seok Lee, Jee Hyun Kim, Seok Yun Kang, Moon Hee Lee, Hee Sook Park, Jin Seok Ahn, Young‐Hyuck Im	2013	54
20	Survival according to Treatment Modalities in 137 Patients with Aplastic Anemia Blood Research ·Hee-Jung Sohn, Reed, PhD, MPH, Megan, Nicole L. Bertsch, Erwin Hadi Chandra, Simona Elena Bealcovschi, Eun-Kyung Kim, Gyeong‐Won Lee, Jae‐Lyun Lee, Min‐Hee Ryu, Seong‐Jun Choi, Je‐Hwan Lee, Sung‐Bae Kim, Sang‐We Kim, Kyoo‐Hyung Lee, Jung‐Shin Lee, Woo-Kun Kim, Cheolwon Suh	2003	0

About Sung‐Bae Kim

Sung‐Bae Kim is a scholar working on Oncology, Otorhinolaryngology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 438 papers that have together received 17.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (99 papers), Cancer Treatment and Pharmacology (89 papers), Breast Cancer Treatment Studies (74 papers), Advanced Breast Cancer Therapies (69 papers), Esophageal Cancer Research and Treatment (54 papers), Cancer Immunotherapy and Biomarkers (43 papers), Head and Neck Cancer Studies (39 papers) and Esophageal and GI Pathology (32 papers). The work is most often cited by research in Oncology (10.1k citations), Cancer Research (2.8k citations), Pulmonary and Respiratory Medicine (5.4k citations), Radiology, Nuclear Medicine and Imaging (3.5k citations) and Otorhinolaryngology (629 citations). Sung‐Bae Kim has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Javier Cortés, Emma Clark, Mark Benyunes, Sandra M. Swain, Graham Ross, Jean-Marc Ferrero, Jungsil Ro, Seock‐Ah Im, Adam Knott and Andreas Schneeweiß. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Research and Treatment, Breast Cancer Research and Treatment and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact